Money Through News Today

There are middlemen between you and pharmaceutical companies that make huge profits from drug prices. They’re called pharmacy benefit managers, or PBMs.

It’s War!

Silvia Stähli-Schönthaler Der Grenchner Hans Kohler war ein Sammler. Rund 4000 Objekte hat der ehemalige Bankangestellte, der 2018 verstorben ist, der Nachwelt hinterlassen. «Dabei handelt es sich vor allem um Flachwaren», sagt Nadine Hunziker, Stiftungsrätin des Kultur-Historischen Museums Grenchen. Denn so werden die vielen Fotos, Postkarten, Inserate, Rechnungen etc. in «Museumssprache» benannt. Alle Sammelobjekte haben mit Grenchen zu tun: Sei es die Ankündigung eines Spiels des ort...

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

3 Points the Media Is Still Getting Wrong About Wuhan Lab Theory, and the Documents to Prove It id Go to Controversial ‘Gain of Function’ Research Thanks to some confusing verbal gymnastics by Dr. Anthony Fauci, some in the media are giving the impression that there’s no proof U.S. tax money funded “gain of function” research or that, perhaps, the research didn’t qualify as gain of function. However, the evidence on this point is clear cut. A 2015 published study specifically disclo...